T. Rowe Price Associates’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-209,641
| Closed | -$1.19M | – | 3162 |
|
|
2025
Q4 | $1.19M | Sell |
209,641
-367,148
| -64% | -$2.07M | ﹤0.01% | 2007 |
|
|
2025
Q3 | $3.53M | Sell |
576,789
-269,472
| -32% | -$1.4M | ﹤0.01% | 1511 |
|
|
2025
Q2 | $2.71M | Sell |
846,261
-59,923
| -7% | -$231K | ﹤0.01% | 1511 |
|
|
2025
Q1 | $3.67M | Sell |
906,184
-21,722
| -2% | -$153K | ﹤0.01% | 1355 |
|
|
2024
Q4 | $9.84M | Sell |
927,906
-7,253
| -0.8% | -$129K | ﹤0.01% | 1155 |
|
|
2024
Q3 | $23.1M | Sell |
935,159
-16,204
| -2% | -$429K | ﹤0.01% | 965 |
|
|
2024
Q2 | $26.8M | Buy |
951,363
+63,527
| +7% | +$2.06M | ﹤0.01% | 883 |
|
|
2024
Q1 | $36.1M | Buy |
887,836
+195,219
| +28% | +$4.6M | ﹤0.01% | 813 |
|
|
2023
Q4 | $11.4M | Sell |
692,617
-52,853
| -7% | -$922K | ﹤0.01% | 1068 |
|
|
2023
Q3 | $28.3M | Sell |
745,470
-3,948
| -0.5% | -$187K | ﹤0.01% | 834 |
|
|
2023
Q2 | $41.2M | Sell |
749,418
-15,002
| -2% | -$688K | 0.01% | 757 |
|
|
2023
Q1 | $32.9M | Buy |
764,420
+38,315
| +5% | +$1.85M | ﹤0.01% | 799 |
|
|
2022
Q4 | $28.5M | Sell |
726,105
-13,452
| -2% | -$706K | ﹤0.01% | 822 |
|
|
2022
Q3 | $39.3M | Sell |
739,557
-153,604
| -17% | -$9.61M | 0.01% | 721 |
|
|
2022
Q2 | $58.6M | Buy |
893,161
+16,792
| +2% | +$1.1M | 0.01% | 827 |
|
|
2022
Q1 | $64.3M | Buy |
876,369
+11,657
| +1% | +$675K | 0.01% | 884 |
|
|
2021
Q4 | $61.2M | Buy |
864,712
+1,890
| +0.2% | +$330K | 0.01% | 937 |
|
|
2021
Q3 | $216M | Buy |
862,822
+126,510
| +17% | +$30.3M | 0.02% | 528 |
|
|
2021
Q2 | $198M | Buy |
736,312
+87,858
| +14% | +$26.3M | 0.02% | 559 |
|
|
2021
Q1 | $185M | Buy |
648,454
+209,036
| +48% | +$66.9M | 0.02% | 577 |
|
|
2020
Q4 | $125M | Buy |
439,418
+7,322
| +2% | +$2.35M | 0.01% | 662 |
|
|
2020
Q3 | $129M | Buy |
432,096
+13,978
| +3% | +$3.34M | 0.01% | 588 |
|
|
2020
Q2 | $84.6M | Buy |
+418,118
| New | +$93.1M | 0.01% | 683 |
|
Other funds holding GBIO
T. Rowe Price Associates's GBIO Position: Q1 2026 in Review
T. Rowe Price Associates sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 209,641 shares — an estimated $1.19M sold.
T. Rowe Price Associates first reported a position in GBIO in Q2 2020 and held it in 23 quarters. The position peaked at $216M in Q3 2021. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.
- T. Rowe Price Associates reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
- T. Rowe Price Associates sold 209,641 Generation Bio shares in Q1 2026, an estimated $1.19M.
- T. Rowe Price Associates first reported a position in Generation Bio in Q2 2020 and held it in 23 quarters.
- T. Rowe Price Associates's Generation Bio position peaked at $216M in Q3 2021.
- 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.
Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.